Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,113 | -7,273 | -35,458 | -28,835 | -18,676 |
| Depreciation Amortization | 100 | 50 | 278 | 224 | 160 |
| Accounts payable and accrued liabilities | -144 | -659 | -174 | -330 | 406 |
| Other Working Capital | 19 | -223 | -3,995 | -4,599 | -3,873 |
| Other Operating Activity | 1,692 | 1,555 | 3,207 | 2,754 | 1,517 |
| Operating Cash Flow | $-12,446 | $-6,550 | $-36,142 | $-30,786 | $-20,466 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -26 | -26 | -26 |
| Sale Of Investment | 1,382 | 742 | 29,774 | 30,047 | 23,534 |
| Investing Cash Flow | $1,382 | $742 | $29,748 | $30,021 | $23,508 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,115 | 196 | 28,297 | 8,271 | 8,189 |
| Other Financing Activity | 0 | 0 | -2,982 | -7,615 | -7,615 |
| Financing Cash Flow | $1,115 | $196 | $25,315 | $656 | $574 |
| Beginning Cash Position | 26,977 | 26,977 | 8,056 | 8,056 | 8,056 |
| End Cash Position | 17,028 | 21,365 | 26,977 | 7,947 | 11,672 |
| Net Cash Flow | $-9,949 | $-5,612 | $18,921 | $-109 | $3,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,446 | -6,550 | -36,142 | -30,786 | -20,466 |
| Capital Expenditure | N/A | N/A | -26 | -26 | -26 |
| Free Cash Flow | -12,446 | -6,550 | -36,168 | -30,812 | -20,492 |